Skip to main content
. 2021 Dec 22;2021:5866468. doi: 10.1155/2021/5866468

Table 3.

Comparison of each item among 28-day survivors and nonsurvivors.

Clinical characteristics Survivors, n = 27 Nonsurvivors, n = 71 p value
Female n, (%) 10 (37%) 21 (29.6%) 0.478
Male n, (%) 17 (63%) 50 (70.4%)
Age, mean 49.51 ± 12.73 60.15 ± 12.91 ≤0.001
 Comorbidities 1 (0–4) 1 (0–7) 0.101
Charlson comorbidity index 2 (0–4) 3 (0–9) ≤0.001
Severity of disease
 SOFA score 6.22 ± 2.53 8.25 ± 2.56 ≤0.001
 APACHE II 14.59 ± 7.11 20.76 ± 6.09 ≤0.001
Biochemical
 Glucose (mg/dL) 154 (77–533) 164 (45–452) 0.387
 Creatinine (mg/dL) 0.83 (0.39–20.23) 1.48 (0.30–13.20) ≤0.001
 BUN (mg/dL) 22.60 (10.50–137) 34 (9–108) ≤0.001
 Albumin (g/dL) 2.59 ± 0.44 2.54 ± 0.50 0.667
 C-reactive protein (mg/dL) 197.37 ± 167.50 199.95 ± 123.78 0.934
Arterial blood gas
 pH 7.35 ± 0.14 7.30 ± 0.14 0.156
 PaCO2 (mmHg) 38 (14–163) 45 (13–114) 0.694
 Bicarbonate (mmol/L) 23.37 ± 7.13 22.50 ± 5.83 0.538
 Lactate (mmol/L) 1.80 (0.60–4.30) 2.10 (0.90–7) 0.056
 PaO2/FiO2 (mmHg) 79 (31–277) 74 (41–366) 0.565
Outcomes
 Mechanical ventilation (days) 9 (3–40) 7 (1–27) 0.024
 Total mNUTRIC-Score, median (IQR), points 2 (0–7) 5 (0–8) ≤0.001
 mNutric-Score level, n (%) 4 (14.8%) 42 (59.2%) ≤0.001
 Hospital length of stay (days) 17 (10–96) 11 (2–28) ≤0.001
 Initial nutrition therapy (hours) 76 (12–240) 72 (24–240) 0.713
Initial time of nutrition therapy
 ≤48 h, n (%) 11 (40.7%) 24 (33.8%) 0.490
 >48 h, n (%) 16 (59.3%) 25 (35.2%)
Complications, n (%)
 Acute kidney injury, n (%) 10 (37%) 52 (73.2%) ≤0.001
 Upper gastrointestinal bleeding, n (%) 2 (7.4%) 4 (5.6%) 0.744
 Vasopressors, n (%) 11 (40.7%) 39 (54.9%) 0.209

Abbreviations: APACHE II, Acute Physiology and Chronic Health Evaluation II; BUN, blood urea nitrogen; mNUTRIC-Score, modified Nutrition Risk in the Critically Ill-Score; IQR, interquartile range; PaCO2, arterial partial carbon dioxide pressure; PaO2/FiO2 ratio, partial pressure of arterial oxygen to fraction of inspired oxygen; SOFA, Sequential Organ Failure Assessment.